|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
GlaxoSmithKline |
|---|---|
| Information provided by: | GlaxoSmithKline |
| ClinicalTrials.gov Identifier: | NCT00046449 |
Purpose
A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
| Condition | Intervention | Phase |
|---|---|---|
|
Seasonal Affective Disorder (SAD) |
Drug: Investigational Seasonal Affective Disorder (SAD) Drug |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria: (Patient must meet these criteria in order to be eligible for this study.)
Exclusion Criteria: (Patient cannot meet these criteria in order to be eligible for this study.)
Contacts and Locations
Show 55 Study Locations
More Information
| Study ID Numbers: | 398149 |
| Study First Received: | September 30, 2002 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00046449 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
Seasonal Affective Disorder Depression Mental Disorders Mood Disorders Depressive Disorder |
|
Seasonal Affective Disorder Pathologic Processes Disease |
Mental Disorders Mood Disorders Depressive Disorder |